Those who follow CGD will be familiar with our branded meme: “Cash on Delivery” aid, or COD. Many are enthusiastic about COD’s potential to revolutionize aid effectiveness. Yet within some global development organizations, leadership and staff alike express common concerns: is COD practical in the real world? Have you thought about this problem, or that constraint? How would this work in the context of our organization? And if we decided to move forward, how would we design a COD grant?
CGD Policy Blogs
UNAIDS and African AIDS Programs Agree That Effective HIV Prevention Depends on Location, Location, Location
As it does every year at this time, UNAIDS has released its World AIDS Day report. With five out of seven HIV infected people living in Africa, it is appropriate that the report is released here at the International Conference on AIDS and STIs in Africa (ICASA) in Harare, Zimbabwe.
You’ve probably already heard about the pharma outrage du jour. In short: start-up Turing Pharmaceuticals, led by combative ex-hedge fund manager Martin Shkreli, recently acquired Daraprim, a 60+ year-old drug to treat a parasitic infection called toxoplasmosis – the only available treatment for this rare infection – which can become deadly for HIV+ individuals and others with weakened immune systems. Turing then promptly raised the price by more than 5000%, from $13.50 to $750 per tablet, such that a single individual’s treatment can now cost up to $634,000.
On Monday, US Secretary of State John Kerry signed an agreement with the African Union to help establish the African Centres for Disease Control and Prevention. Headquartered in Addis Ababa, Ethiopia, the African CDC will take on a role similar to the Centers for Disease Control and Prevention (CDC) in the United States, and work to prevent and respond to future disease outbreaks on the continent.